Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients

Background. Rifampicin is a pillar in the treatment of periprosthetic joint infection (PJI). However, rifampicin resistance is an increasing threat to PJI treatment. This study explores the incidence of rifampicin-resistant bacteria over time in a Swedish tertiary referral centre and the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazarinis, Stergios, Hailer, Nils P., Järhult, Josef D., Brüggemann, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603907/
https://www.ncbi.nlm.nih.gov/pubmed/37887200
http://dx.doi.org/10.3390/antibiotics12101499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603907/
https://www.ncbi.nlm.nih.gov/pubmed/37887200
http://dx.doi.org/10.3390/antibiotics12101499

Ejemplares similares